The U.S. Food and Drug Administration (FDA) on Wednesday approved GSK Plc's drug as the first oral treatment for anemia caused by chronic kidney disease in adults who have been on dialysis for at least four months.
Feb 1 - The U.S. Food and Drug Administration on Wednesday approved GSK Plc's
The drug Jesduvroq comes with the boxed warning for increased thrombotic vascular events, including death, heart attack, stroke, and blood clots in the lungs, legs, or dialysis access site. The warnings and precautions also include a risk of hospitalization for heart failure, worsening increase of blood pressure, stomach erosions, and gastrointestinal bleeding.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA proposes new levels for lead in baby foodThe Food and Drug Administration has released new draft guidance regarding levels of lead in baby food.
Read more »
FDA creates food safety, nutrition program in wake of baby formula crisisCommissioner Robert M. Califf will appoint a new deputy commissioner with broad powers, but some food safety advocates say the move is not enough.
Read more »
FDA commissioner reveals proposed plan to reorganize regulatory food programsThe FDA has faced scrutiny in recent years for its oversight of food products.
Read more »
FDA announces a restructuring of the agency's food safety and nutrition divisionThe FDA is appointing a deputy commissioner of 'human food,' to oversee food safety and nutrition. The move follows the baby formula shortage crisis and other outbreaks of food-borne illness.
Read more »
Mobile food market providing fresh food to those in underserved communitiesTaking care of your heart is very important for your health. That’s why the American Heart Association is working with San Antonio community partners and health organizations to improve the health and wellness of those in the community.
Read more »
GSK Q4 results beat expectations, helped by ShingrixGSK on Wednesday beat fourth-quarter profit and sales forecasts helped by sales of its blockbuster shingles vaccine Shingrix.
Read more »